*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

Call/VB 
[ it/PRP ]

[ the/DT other/JJ drug/NN war/NN ]
./. 

======================================

Do/VBP n't/RB expect/VB to/TO see/VB 
[ this/DT one/CD ]
on/IN 
[ the/DT evening/NN news/NN ]
,/, for/IN most/JJS of/IN 
[ the/DT fighting/NN ]
is/VBZ hidden/VBN from/IN 
[ public/JJ view/NN ]
./. 

[ The/DT battles/NNS ]
nonetheless/RB affect/VBP 
[ every/DT American/JJ doctor/NN ]
,/, 
[ a/DT raft/NN ]
of/IN 
[ popular/JJ medicines/NNS ]
,/, and/CC 
[ countless/JJ patients/NNS ]
and/CC 
[ medical/JJ insurance/NN companies/NNS ]
./. 

======================================

[ This/DT ]
is/VBZ 
[ the/DT drug/NN industry/NN war/NN ]
,/, 
[ a/DT bitter/JJ clash/NN ]
between/IN 
[ such/JJ pharmaceutical/JJ powerhouses/NNS ]
as/IN 
[ Pfizer/NNP Inc./NNP ]
and/CC 
[ dozens/NNS ]
of/IN 
[ corporate/JJ small/JJ fry/NN ]

[ that/WDT ]
make/VBP and/CC sell/VBP 
[ the/DT less-expensive/JJ ]
,/, 
[ generic/JJ versions/NNS ]
of/IN 
[ the/DT big/JJ companies/NNS '/POS drugs/NNS ]
./. 

======================================

While/IN 
[ the/DT two/CD camps/NNS ]
have/VBP competed/VBN aggressively/RB for/IN 
[ years/NNS ]
,/, lately/RB 
[ the/DT fight/NN ]
has/VBZ turned/VBN 
[ ferocious/JJ ]
--/: and/CC often/RB damaging/JJ to/TO 
[ the/DT public/NN ]
./. 

[ The/DT big/JJ companies/NNS ]
have/VBP 
[ underwritten/VBN scientific/JJ studies/NNS ]
damning/VBG 
[ the/DT safety/NN ]
of/IN 
[ generic/JJ drugs/NNS ]
and/CC have/VBP used/VBN 
[ them/PRP ]
to/TO frighten/VB 
[ state/NN bureaucrats/NNS ]
and/CC 
[ lawmakers/NNS ]
into/IN restricting/VBG 
[ generic/JJ drug/NN use/NN ]
./. 

[ They/PRP ]
have/VBP also/RB paid/VBN 
[ doctors/NNS ]
and/CC 
[ publicists/NNS ]
to/TO spread/VB 
[ unsubstantiated/JJ tales/NNS ]
of/IN 
[ ill/JJ effects/NNS ]
caused/VBN by/IN 
[ generic/JJ medicines/NNS ]
./. 

Recently/RB ,/, 
[ federal/JJ regulators/NNS ]
called/VBD 
[ several/JJ ]
of/IN 
[ these/DT campaigns/NNS ]
``/`` 
[ false/JJ ]
and/CC 
[ misleading/JJ ]
./. 

''/'' 
======================================

But/CC 
[ many/JJ ]
of/IN 
[ the/DT generic/JJ makers/NNS ]
give/VBP as/RB good/JJ as/IN 
[ they/PRP ]
get/VBP ,/, lobbying/VBG 
[ states/NNS ]
to/TO mandate/VB 
[ use/NN ]
of/IN 
[ their/PRP$ lower-cost/JJ products/NNS ]
./. 

[ Lawsuits/NNS ]
challenging/VBG 
[ brand-name/JJ drug/NN patents/NNS ]
abound/VBP ./. 

[ Company/NN budgets/NNS ]
for/IN 
[ lawyers/NNS ]
and/CC 
[ lobbyists/NNS ]
sometimes/RB exceed/VBP 
[ research/NN ]
and/CC 
[ development/NN costs/NNS ]
./. 

And/CC as/RB current/JJ highly/RB publicized/VBN 
[ disclosures/NNS ]
from/IN 
[ a/DT congressional/JJ investigation/NN show/VBP ]
,/, 
[ a/DT few/JJ executives/NNS ]
of/IN 
[ generics/NNS companies/NNS ]
have/VBP bribed/VBN 
[ federal/JJ officials/NNS ]
while/IN 
[ others/NNS ]
cheated/VBD on/IN 
[ applications/NNS ]
to/TO win/VB 
[ federal/JJ approval/NN ]
of/IN 
[ their/PRP$ drugs/NNS ]
./. 

======================================

[ There/EX ]
is/VBZ even/RB 
[ evidence/NN ]

[ the/DT government/NN 's/POS current/JJ probe/NN ]
into/IN 
[ generics/NNS ]
--/: 
[ which/WDT ]
,/, notably/RB ,/, was/VBD initially/RB sparked/VBN by/IN 
[ complaints/NNS ]
from/IN 
[ generics-maker/NN Mylan/NNP Laboratories/NNP Inc./NNP ]
--/: has/VBZ been/VBN further/RB fueled/VBN by/IN 
[ information/NN ]
supplied/VBN by/IN 
[ the/DT brand-name/JJ companies/NNS ]
./. 

At/IN 
[ the/DT very/RB least/JJS ]
,/, 
[ the/DT probe/NN ]
has/VBZ intensified/VBN 
[ this/DT hidden/JJ drug/NN war/NN ]
./. 

======================================

``/`` 
[ The/DT sharks/NNS ]
are/VBP surfacing/VBG ,/, ''/'' says/VBZ 
[ William/NNP Haddad/NNP ]
,/, 
[ chairman/NN ]
of/IN privately/RB owned/VBN 
[ Danbury/NNP Pharmacal/NNP Inc/NNP ]
./. 

======================================

As/IN 
[ head/NN ]
of/IN 
[ the/DT Generic/NNP Pharmaceutical/NNP Industry/NNP Association/NNP ]
,/, 
[ Mr./NNP Haddad/NNP ]
is/VBZ 
[ a/DT veteran/NN ]
of/IN 
[ past/JJ industry/NN skirmishes/NNS ]
./. 

[ He/PRP ]
is/VBZ convinced/JJ that/IN 
[ brand-name/JJ companies/NNS ]
and/CC 
[ others/NNS hostile/JJ ]
to/TO 
[ generic/JJ drugs/NNS ]
are/VBP unfairly/RB exploiting/VBG 
[ the/DT scandal/NN ]
./. 

======================================

In/IN 
[ August/NNP ]
,/, 
[ pharmaceutical/JJ company/NN representatives/NNS ]
passed/VBD out/RP 
[ a/DT sheaf/NN ]
of/IN 
[ articles/NNS ]
about/IN 
[ the/DT scandal/NN ]
to/TO 
[ members/NNS ]
of/IN 
[ the/DT New/NNP Jersey/NNP senate/NN ]
./. 

[ They/PRP ]
were/VBD hoping/VBG to/TO torpedo/VB 
[ a/DT measure/NN ]

[ the/DT senate/NN ]
was/VBD considering/VBG to/TO facilitate/VB 
[ the/DT substitution/NN ]
of/IN 
[ generic/JJ drugs/NNS ]
for/IN 
[ brand/NN names/NNS ]
./. 

And/CC 
[ they/PRP ]
succeeded/VBD ./. 

======================================

In/IN 
[ the/DT packet/NN ]
was/VBD 
[ a/DT cover/NN letter/NN ]
to/TO 
[ each/DT state/NN senator/NN ]
from/IN 
[ the/DT New/NNP Jersey/NNP Health/NNP Products/NNP Council/NNP ]
,/, 
[ a/DT consortium/NN ]

[ that/WDT ]
includes/VBZ 
[ such/JJ major/JJ drug/NN makers/NNS ]
as/IN 
[ Merck/NNP ]
&/CC 
[ Co./NNP ]
,/, 
[ Johnson/NNP ]
&/CC 
[ Johnson/NNP ]
,/, 
[ Ciba-Geigy/NNP Corp./NNP ]
and/CC 
[ Squibb/NNP Corp/NNP ]
./. 

[ The/DT letter/NN ]
said/VBD ,/, ``/`` 
[ There/EX ]
can/MD be/VB 
[ major/JJ complications/NNS ]
when/WRB 
[ drugs/NNS ]
made/VBN by/IN 
[ different/JJ companies/NNS ]
are/VBP switched/VBN ,/, especially/RB for/IN 
[ our/PRP$ senior/JJ citizens/NNS ]

[ who/WP ]
often/RB take/VBP 
[ a/DT number/NN ]
of/IN 
[ different/JJ medications/NNS ]
./. 

''/'' (/( 
[ The/DT Food/NNP ]
and/CC 
[ Drug/NNP Administration/NNP ]
says/VBZ 
[ there/EX ]
is/VBZ 
[ no/DT scientific/JJ evidence/NN ]
to/TO back/VB 
[ this/DT contention/NN ]
./. 

 )/) 
======================================

``/`` 
[ We/PRP ]
felt/VBD 
[ we/PRP ]
had/VBD 
[ votes/NNS ]
to/TO pass/VB 
[ the/DT bill/NN ]
,/, ''/'' says/VBZ 
[ Melanie/NNP Willoughby/NNP ]
,/, 
[ a/DT lobbyist/NN ]
for/IN 
[ the/DT pharmacy/NN industry/NN ]
,/, 
[ which/WDT ]
would/MD have/VB benefited/VBN from/IN 
[ the/DT measure/NN ]
./. 

``/`` But/CC 
[ all/DT morning/NN senators/NNS ]
came/VBD up/IN to/TO 
[ me/PRP ]
quoting/VBG from/IN 
[ the/DT letter/NN ]
and/CC 
[ the/DT articles/NNS ]
and/CC 
[ saying/VBG things/NNS ]
like/IN 
[ 'I/NN ]
did/VBD n't/RB know/VB 
[ this/DT ]
./. 

'/'' ``/`` 
======================================

[ The/DT generics/NNS industry/NN ]
fought/VBD back/RP in/IN 
[ kind/NN ]
./. 

When/WRB 
[ reporters/NNS ]
called/VBD 
[ Mr./NNP Haddad/NNP ]
in/IN 
[ September/NNP ]
asking/VBG for/IN 
[ comment/NN ]
about/IN 
[ recent/JJ manufacturing/NN problems/NNS ]
uncovered/VBN at/IN 
[ generics/NNS firms/NNS ]
,/, 
[ he/PRP ]
countered/VBD by/IN directing/VBG 
[ them/PRP ]
to/TO 
[ an/DT unpublicized/JJ FDA/NNP report/NN ]
criticizing/VBG 
[ manufacturing/NN practices/NNS ]
at/IN 
[ Eli/NNP Lilly/NNP ]
&/CC 
[ Co./NNP ]
,/, 
[ a/DT major/JJ brand-name/JJ drug/NN maker/NN ]
./. 

[ Subsequent/JJ news/NN reports/NNS ]
about/IN 
[ Lilly/NNP ]
triggered/VBD 
[ a/DT major/JJ review/NN ]
of/IN 
[ the/DT company/NN 's/POS plants/NNS ]
world-wide/RB by/IN 
[ federal/JJ investigators/NNS ]
./. 

======================================

When/WRB 
[ the/DT press/NN ]
reported/VBD 
[ an/DT incident/NN ]
involving/VBG 
[ the/DT recall/NN ]
of/IN 
[ a/DT generic/JJ epilepsy/NN drug/NN ]
,/, 
[ Mr./NNP Haddad/NNP 's/POS trade/NN group/NN ]
countered/VBD by/IN sending/VBG 
[ reporters/NNS ]

[ a/DT list/NN ]
of/IN 
[ 10/CD ]
recalls/NNS involving/VBG 
[ brand-name/JJ drugs/NNS ]
in/IN 
[ 1988/CD ]
and/CC 
[ 1989/CD ]
./. 

``/`` 
[ Bill/NNP ]
is/VBZ 
[ an/DT old-fashioned/JJ political/JJ streetfighter/NN ]
,/, and/CC 
[ that/DT ]
's/VBZ why/WRB 
[ we/PRP ]
have/VBP 
[ him/PRP ]
on/IN 
[ our/PRP$ side/NN ]
,/, ''/'' says/VBZ 
[ an/DT executive/NN ]
at/IN 
[ one/CD generics/NNS company/NN ]
./. 

======================================

While/IN 
[ much/JJ ]
of/IN 
[ the/DT squabbling/NN ]
may/MD appear/VB 
[ unseemly/JJ ]
and/CC 
[ petty/JJ ]
,/, 
[ the/DT financial/JJ stakes/NNS ]
are/VBP huge/JJ ./. 

Between/IN 
[ 1991/CD ]
and/CC 
[ 1995/CD ]
,/, 
[ patents/NNS ]
will/MD expire/VB on/IN 
[ brand-name/JJ prescription/NN drugs/NNS ]
with/IN 
[ an/DT estimated/JJ $/$ 10/CD billion/CD ]
in/IN 
[ annual/JJ sales/NNS ]
./. 

[ Generics/NNS firms/NNS ]

[ that/WDT ]
can/MD snatch/VB 
[ a/DT share/NN ]
of/IN 
[ that/DT booty/NN ]
can/MD flourish/VB ,/, at/IN 
[ the/DT expense/NN ]
of/IN 
[ the/DT pharmaceutical/JJ giants/NNS ]
./. 

 (/( Ironically/RB ,/, 
[ several/JJ big/JJ drug/NN makers/NNS ]
have/VBP 
[ divisions/NNS ]

[ that/WDT ]
sell/VBP 
[ generic/JJ drugs/NNS ]
./. 

[ Sales/NNS ]
from/IN 
[ those/DT units/NNS ]
,/, however/RB ,/, are/VBP only/RB 
[ a/DT fraction/NN ]
of/IN 
[ the/DT companies/NNS '/POS total/NN revenue/NN ]
./. 

 )/) 
[ One/CD generics/NNS maker/NN ]
,/, 
[ Chase/NNP Chemical/NNP Corp./NNP ]
of/IN 
[ Newark/NNP ]
,/, 
[ N.J./NNP ]
,/, is/VBZ seeking/VBG to/TO market/VB 
[ a/DT version/NN ]
of/IN 
[ Pfizer/NNP 's/POS blood-pressure/NN drug/NN Procardia/NNP ]
,/, 
[ a/DT ]
hugely/RB 
[ profitable/JJ product/NN ]
with/IN about/RB 
[ $/$ 400/CD million/CD ]
in/IN 
[ yearly/JJ sales/NNS ]
./. 

[ Procardia/NNP ]
will/MD account/VB for/IN nearly/RB 
[ 15/CD %/NN ]
of/IN 
[ Pfizer/NNP 's/POS expected/JJ $/$ 736/CD million/CD ]
in/IN 
[ profit/NN ]

[ this/DT year/NN ]
,/, 
[ securities/NNS analysts/NNS ]
estimate/VBP ./. 

[ The/DT FDA/NNP ]
has/VBZ cleared/VBN 
[ Chase/NNP ]
to/TO sell/VB 
[ a/DT generic/JJ copy/NN ]
of/IN 
[ the/DT drug/NN ]
,/, but/CC 
[ Pfizer/NNP ]
has/VBZ filed/VBN 
[ a/DT patent-infringement/NN suit/NN ]
against/IN 
[ Chase/NNP ]
and/CC tied/VBN 
[ it/PRP ]
up/RP in/IN 
[ court/NN ]
./. 

======================================

Or/CC consider/VB 
[ Warner-Lambert/NNP Co./NNP ]
,/, 
[ which/WDT ]
successfully/RB lobbied/VBD with/IN 
[ Congress/NNP last/JJ year/NN ]
for/IN 
[ a/DT special/JJ law/NN extending/VBG patent/NN protection/NN ]
for/IN 
[ its/PRP$ anti-cholesterol/JJ drug/NN ]
,/, 
[ Lopid/NNP ]
./. 

[ The/DT extension/NN ]
to/TO 
[ 1993/CD ]
effectively/RB delayed/VBD 
[ generic/JJ competition/NN ]
for/IN 
[ four/CD years/NNS ]
,/, and/CC was/VBD so/RB important/JJ to/TO 
[ the/DT company/NN ]
that/IN 
[ Joseph/NNP Williams/NNP ]
,/, 
[ the/DT concern/NN 's/POS chairman/NN ]
and/CC 
[ chief/JJ executive/NN ]
,/, made/VBD 
[ 28/CD trips/NNS ]
to/TO 
[ Washington/NNP ]
over/IN 
[ 20/CD months/NNS ]
to/TO talk/VB to/TO 
[ 60/CD representatives/NNS ]
and/CC 
[ senators/NNS ]
./. 

[ The/DT drug/NN ]
is/VBZ expected/VBN to/TO generate/VB about/RB 
[ $/$ 300/CD million/CD ]
in/IN 
[ sales/NNS ]
for/IN 
[ Warner-Lambert/NNP ]

[ this/DT year/NN ]
./. 

[ The/DT company/NN ]
said/VBD 
[ it/PRP ]
deserves/VBZ 
[ the/DT extension/NN ]
because/IN 
[ it/PRP ]
had/VBD plowed/VBN so/RB much/JJ into/IN 
[ research/NN ]
./. 

======================================

[ Little/JJ ]
wonder/NN ,/, then/RB ,/, that/IN 
[ brand-name/JJ makers/NNS ]
have/VBP provided/VBN 
[ federal/JJ investigators/NNS ]
many/JJ of/IN 
[ the/DT leads/NNS ]
in/IN 
[ the/DT current/JJ probe/NN ]
of/IN 
[ generics/NNS ]
./. 

[ The/DT firm/NN ]
now/RB known/VBN as/IN 
[ SmithKline/NNP Beecham/NNP PLC/NNP ]
has/VBZ been/VBN especially/RB aggressive/JJ in/IN trying/VBG to/TO knock/VB out/RP 
[ competition/NN ]
to/TO 
[ its/PRP$ hypertension/NN drug/NN Dyazide/NNP ]
./. 

In/IN 
[ 1987/CD ]
,/, 
[ the/DT FDA/NNP ]
approved/VBD 
[ two/CD generic/JJ versions/NNS ]
,/, 
[ one/CD ]
made/VBN by/IN 
[ Bolar/NNP Pharmaceutical/NNP Co./NNP ]
and/CC 
[ another/DT ]
by/IN 
[ Vitarine/NNP Pharmaceuticals/NNP Inc/NNP ]
./. 

[ Both/DT ]

[ companies/NNS ]
have/VBP been/VBN 
[ principal/JJ targets/NNS ]
of/IN 
[ the/DT generics/NNS investigation/NN ]
by/IN 
[ a/DT subcommittee/NN ]
chaired/VBN by/IN 
[ Rep./NNP John/NNP Dingell/NNP ]
,/, 
[ the/DT Michigan/NNP Democrat/NNP ]
./. 

======================================

In/IN 
[ 1988/CD ]
,/, 
[ SmithKline/NNP ]
complained/VBD to/TO 
[ the/DT FDA/NNP ]

[ that/WDT ]
,/, contrary/JJ to/TO 
[ what/WP ]

[ Bolar/NNP ]
said/VBD ,/, 
[ Bolar/NNP 's/POS product/NN was/VBD n't/RB ]
equivalent/JJ to/TO 
[ Dyazide/NNP ]
./. 

As/IN 
[ a/DT result/NN ]
,/, 
[ an/DT FDA/NNP inspection/NN report/NN ]
says/VBZ ,/, 
[ the/DT agency/NN ]
examined/VBD 
[ samples/NNS ]
of/IN 
[ Bolar/NNP 's/POS test/NN product/NN ]
./. 

During/IN 
[ the/DT inspection/NN ]

[ this/DT spring/NN ]
,/, 
[ the/DT FDA/NNP ]
received/VBD 
[ a/DT second/JJ complaint/NN ]
from/IN 
[ SmithKline/NNP ]
via/IN 
[ Rep./NNP Dingell/NNP 's/POS subcommittee/NN ]
./. 

[ It/PRP ]
charged/VBD that/IN 
[ Bolar/NNP 's/POS product/NN ]
did/VBD n't/RB contain/VB 
[ proper/JJ amounts/NNS ]
of/IN 
[ the/DT drug/NN 's/POS active/JJ ingredients/NNS ]
./. 

======================================

In/IN 
[ a/DT letter/NN ]
to/TO 
[ FDA/NNP commissioner/NN Frank/NNP Young/NNP ]
in/IN 
[ June/NNP ]
,/, 
[ the/DT subcommittee/NN ]
acknowledged/VBD that/IN 
[ SmithKline/NNP ]
had/VBD provided/VBN 
[ it/PRP ]
with/IN 
[ test/NN studies/NNS ]
of/IN 
[ both/CC ]

[ the/DT Bolar/NNP ]
and/CC 
[ Vitarine/NNP products/NNS ]
./. 

[ Subsequently/NNP ]
,/, 
[ the/DT FDA/NNP ]
found/VBD that/IN ,/, in/IN 
[ fact/NN ]
,/, 
[ Vitarine/NNP ]
had/VBD cheated/VBN by/IN substituting/VBG 
[ SmithKline/NNP 's/POS drug/NN ]
for/IN 
[ its/PRP$ own/JJ ]
when/WRB 
[ it/PRP ]
applied/VBD for/IN (/( and/CC received/VBD )/) 
[ FDA/NNP approval/NN ]
./. 

[ The/DT FDA/NNP ]
pulled/VBD 
[ the/DT drug/NN ]
from/IN 
[ the/DT market/NN ]
./. 

[ The/DT FDA/NNP probe/NN ]
also/RB found/VBD that/IN 
[ Bolar/NNP ]
had/VBD n't/RB followed/VBN 
[ proper/JJ procedure/NN ]
when/WRB 
[ it/PRP ]
received/VBD 
[ FDA/NNP approval/NN ]
for/IN 
[ its/PRP$ version/NN ]
./. 

[ The/DT agency/NN ]
did/VBD n't/RB ban/VB 
[ Bolar/NNP 's/POS product/NN ]
but/CC said/VBD that/IN until/IN 
[ new/JJ studies/NNS ]
are/VBP completed/VBN ,/, 
[ it/PRP ]
is/VBZ n't/RB considered/VBN 
[ interchangeable/JJ ]
with/IN 
[ Dyazide/NNP ]
./. 

But/CC 
[ the/DT FDA/NNP ]
is/VBZ n't/RB contending/VBG 
[ Bolar/NNP 's/POS drug/NN ]
is/VBZ n't/RB safe/JJ and/CC 
[ effective/JJ ]
./. 

======================================

[ SmithKline/NNP ]
is/VBZ n't/RB 
[ the/DT only/JJ company/NN ]
to/TO exploit/VB 
[ congressional/JJ interest/NN ]
in/IN 
[ Bolar/NNP ]
./. 

[ Warner-Lambert/NNP ]
sent/VBD 
[ the/DT FDA/NNP ]
and/CC 
[ the/DT House/NNP investigators/NNS ]

[ a/DT study/NN ]

[ it/PRP ]
had/VBD funded/VBN questioning/VBG 
[ the/DT quality/NN ]
of/IN 
[ Bolar/NNP 's/POS version/NN ]
of/IN 
[ Dilantin/NNP ]
,/, 
[ an/DT anti-epilepsy/JJ drug/NN ]
sold/VBN by/IN 
[ Warner-Lambert/NNP 's/POS Parke-Davis/NNP division/NN ]
./. 

``/`` 
[ We/PRP ]
figured/VBD with/IN 
[ all/DT ]

[ that/WDT ]
's/VBZ going/VBG on/RP ,/, 
[ the/DT FDA/NNP ]
might/MD find/VB 
[ our/PRP$ study/NN ]
of/IN 
[ interest/NN ]
,/, ''/'' 
[ a/DT Warner-Lambert/NNP official/NN ]
says/VBZ ./. 

[ Carl/NNP Peck/NNP ]
,/, 
[ a/DT top/JJ FDA/NNP staffer/NN ]
,/, says/VBZ 
[ the/DT agency/NN ]
quickly/RB agreed/VBD to/TO review/VB 
[ the/DT Warner-Lambert/NNP study/NN ]
,/, noting/VBG that/IN ``/`` 
[ any/DT questions/NNS ]
about/IN 
[ an/DT anti-convulsive/JJ drug/NN ]
receive/VBP 
[ prompt/JJ attention/NN ]
./. 

''/'' 
======================================

[ A/DT review/NN ]
of/IN 
[ the/DT study/NN ]
failed/VBD to/TO find/VB 
[ specific/JJ problems/NNS ]
with/IN 
[ Bolar/NNP 's/POS product/NN ]
./. 

But/CC 
[ the/DT review/NN ]
has/VBZ triggered/VBN 
[ a/DT separate/JJ FDA/NNP probe/NN ]
of/IN 
[ Bolar/NNP 's/POS original/JJ application/NN ]
for/IN 
[ the/DT drug/NN ]
./. 

[ Rep./NNP Dingell/NNP ]
has/VBZ said/VBD that/IN ,/, based/VBN on/IN 
[ the/DT Warner-Lambert/NNP complaint/NN ]
and/CC 
[ other/JJ facts/NNS ]
,/, 
[ the/DT subcommittee/NN ]
has/VBZ ``/`` 
[ no/DT confidence/NN ]
''/'' that/IN 
[ generic/JJ anti-epileptic/JJ drugs/NNS ]
are/VBP safe/JJ ./. 

======================================

[ There/EX ]
is/VBZ 
[ evidence/NN ]
suggesting/VBG 
[ that/DT big/JJ drug/NN makers/NNS ]
have/VBP used/VBN 
[ close/JJ ties/NNS ]
to/TO 
[ the/DT FDA/NNP ]
to/TO block/VB release/NN of/IN 
[ some/DT generics/NNS ]
./. 

[ One/CD generics/NNS maker/NN ]
,/, 
[ Barr/NNP Laboratories/NNP Inc./NNP ]
of/IN 
[ Pomona/NNP ]
,/, 
[ N.Y./NNP ]
,/, asserts/VBZ that/IN 
[ American/NNP Home/NNP Products/NNP Corp./NNP 's/POS Wyeth-Ayerst/NNP Laboratories/NNP ]
has/VBZ persuaded/VBN 
[ the/DT FDA/NNP ]
to/TO delay/VB 
[ release/NN ]
of/IN 
[ Barr/NNP 's/POS copy/NN ]
of/IN 
[ the/DT estrogen/NN drug/NN Premarin/NNP ]
./. 

[ Premarin/NNP ]
,/, 
[ which/WDT ]
is/VBZ made/VBN by/IN 
[ Wyeth-Ayerst/NNP ]
,/, treats/VBZ 
[ symptoms/NNS ]
of/IN 
[ menopause/NN ]
and/CC helps/VBZ prevent/VB 
[ osteoporosis/NN ]
,/, 
[ a/DT weakening/NN ]
of/IN 
[ the/DT bones/NNS ]
./. 

======================================

In/IN early/JJ 
[ 1988/CD ]
,/, 
[ Barr/NNP ]
received/VBD 
[ two/CD letters/NNS ]
from/IN 
[ the/DT FDA/NNP ]
indicating/VBG 
[ the/DT agency/NN ]
was/VBD about/RB to/TO let/VB 
[ the/DT company/NN ]
sell/VB 
[ a/DT generic/JJ version/NN ]
of/IN 
[ Premarin/NNP ]
./. 

``/`` 
[ We/PRP ]
thought/VBD 
[ we/PRP ]
had/VBD 
[ a/DT winner/NN ]
,/, ''/'' says/VBZ 
[ Larry/NNP Fox/NNP ]
,/, 
[ a/DT Barr/NNP lawyer/NN ]
./. 

======================================

But/CC 
[ the/DT FDA/NNP ]
put/VBD 
[ the/DT approval/NN ]
on/IN 
[ hold/NN ]
in/IN 
[ June/NNP ]
of/IN 
[ that/DT year/NN ]
./. 

As/IN 
[ it/PRP ]
turns/VBZ out/IN ,/, 
[ Wyeth-Ayerst/NNP ]
had/VBD persuaded/VBN 
[ the/DT FDA/NNP ]
to/TO change/VB 
[ the/DT agency/NN 's/POS guidelines/NNS ]
for/IN approving/VBG 
[ copies/NNS ]
of/IN 
[ drugs/NNS ]
like/IN 
[ Premarin/NNP ]
./. 

[ Wyeth-Ayerst/NNP ]
insisted/VBD that/IN determining/VBG whether/IN 
[ Barr/NN 's/POS drug/NN ]
was/VBD ``/`` 
[ bioequivalent/JJ ]
''/'' --/: released/VBN in/IN 
[ the/DT body/NN ]
similarly/RB to/TO 
[ the/DT way/NN Premarin/NNP ]
is/VBZ --/: should/MD be/VB measured/VBN by/IN 
[ blood/NN tests/NNS ]
rather/RB than/IN 
[ urine/NN tests/NNS ]
,/, as/RB originally/RB prescribed/VBN by/IN 
[ the/DT FDA/NNP ]
./. 

======================================

[ Peter/NNP H./NNP Rheinstein/NNP ]
,/, 
[ director/NN ]
of/IN 
[ the/DT FDA/NNP 's/POS office/NN ]
of/IN 
[ drug/NN standards/NNS ]
,/, confirms/VBZ in/IN 
[ a/DT sworn/JJ statement/NN ]
that/IN 
[ Barr/NNP 's/POS apparent/JJ approval/NN ]
is/VBZ being/VBG held/VBN up/RP because/RB of/IN 
[ Wyeth-Ayerst/NNP 's/POS argument/NN ]
./. 

[ Dr./NNP Rheinstein/NNP 's/POS affidavit/NN ]
is/VBZ filed/VBN with/IN 
[ the/DT federal/JJ court/NN ]
in/IN 
[ Washington/NNP ]
where/WRB 
[ Barr/NNP ]
is/VBZ suing/VBG 
[ the/DT FDA/NNP ]
,/, alleging/VBG that/IN 
[ the/DT agency/NN ]
leaked/VBD 
[ confidential/JJ information/NN ]
about/IN 
[ Barr/NNP 's/POS application/NN ]
to/TO 
[ Wyeth-Ayerst/NNP ]
./. 

======================================

``/`` 
[ They/PRP ]
 {/( 
[ Wyeth-Ayerst/NNP ]
 }/) do/VBP n't/RB have/VB 
[ the/DT right/NN ]
to/TO establish/VB 
[ standards/NNS ]
of/IN 
[ the/DT U.S./NNP government/NN ]
,/, ''/'' says/VBZ 
[ Mr./NNP Fox/NNP ]
./. 

======================================

[ Some/DT ]
of/IN 
[ the/DT most/RBS heated/JJ tiffs/NNS ]
in/IN 
[ the/DT industry/NN result/VBP ]
from/IN 
[ claims/NNS ]
by/IN 
[ some/DT brand-name/JJ companies/NNS ]
that/IN switching/VBG 
[ patients/NNS ]
to/TO 
[ generic/JJ drugs/NNS ]
can/MD cause/VB 
[ health/NN problems/NNS ]
./. 

[ Ciba-Geigy/NNP ]
,/, 
[ the/DT U.S./NNP unit/NN ]
of/IN 
[ Swiss/JJ drug/NN maker/NN Ciba-Geigy/NNP Ltd./NNP ]
,/, has/VBZ used/VBN 
[ this/DT tactic/NN ]
in/IN trying/VBG to/TO protect/VB 
[ its/PRP$ anti-epilepsy/JJ drug/NN Tegretol/NNP ]
./. 

[ Its/PRP$ maneuvering/NN ]
raised/VBD 
[ the/DT ire/NN ]
of/IN 
[ the/DT FDA/NNP ]
,/, 
[ which/WDT ]
called/VBD 
[ one/CD company/NN campaign/NN ]

[ an/DT attempt/NN ]
to/TO ``/`` influence/VB 
[ government/NN decisions/NNS ]
''/'' based/VBN on/IN ``/`` 
[ misleading/JJ ]
and/CC 
[ unsupported/JJ allegations/NNS ]
./. 

''/'' 
======================================

[ An/DT FDA/NNP investigation/NN ]
found/VBD that/IN 
[ Ciba-Geigy/NNP ]
paid/VBD 
[ a/DT marketing/NN firm/NN ]
to/TO 
[ drum/NN ]
up/IN 
[ mailgrams/NNS ]
from/IN 
[ doctors/NNS ]
and/CC 
[ pharmacists/NNS ]

[ that/WDT ]
were/VBD sent/VBN to/TO 
[ officials/NNS ]
in/IN 
[ California/NNP ]
and/CC 
[ other/JJ states/NNS ]
./. 

At/IN 
[ the/DT time/NN ]
,/, 
[ Ciba-Geigy/NNP ]
was/VBD arguing/VBG that/IN 
[ the/DT states/NNS ]
should/MD n't/RB encourage/VB use/NN of/IN 
[ the/DT generic/JJ drugs/NNS ]
by/IN 
[ Medicaid/NNP recipients/NNS ]
,/, and/CC ,/, particularly/RB ,/, that/IN 
[ generic/JJ anti-epilepsy/JJ drugs/NNS ]
should/MD n't/RB be/VB substituted/VBN for/IN 
[ brand-name/JJ ones/NNS ]
./. 

[ The/DT mailgrams/NNS ]
appeared/VBD as/IN if/IN 
[ they/PRP ]
were/VBD sent/VBN by/IN 
[ individuals/NNS ]
,/, but/CC were/VBD actually/RB sent/VBN by/IN 
[ Targetted/NNP Communications/NNP Corp./NNP ]
,/, of/IN 
[ McLean/NNP ]
,/, 
[ Va./NNP ]
,/, 
[ which/WDT ]
had/VBD contacted/VBN 
[ the/DT health/NN professionals/NNS ]
,/, asked/VBN if/IN 
[ their/PRP$ names/NNS ]
could/MD be/VB used/VBN and/CC then/RB typed/VBN in/IN 
[ their/PRP$ names/NNS ]
at/IN 
[ the/DT bottom/NN ]
of/IN 
[ the/DT mailgrams/NNS ]
./. 

[ One/CD mailgram/NN ]
said/VBD ,/, for/IN 
[ instance/NN ]
,/, that/IN switching/VBG 
[ the/DT products/NNS ]
``/`` could/MD cause/VB increased/JJ 
[ seizures/NNS ]
./. 

''/'' 
======================================

But/CC 
[ the/DT FDA/NNP ]
says/VBZ 
[ there/EX ]
is/VBZ n't/RB 
[ any/DT evidence/NN ]
to/TO back/VB 
[ such/PDT a/DT claim/NN ]
./. 

Moreover/RB ,/, in/IN 
[ a/DT letter/NN ]
reprimanding/VBG 
[ the/DT company/NN ]
in/IN 
[ April/NNP ]
,/, 
[ the/DT FDA/NNP ]
said/VBD 
[ it/PRP ]
doubts/VBZ ``/`` 
[ these/DT individual/JJ pharmacists/NNS ]
had/VBD 
[ any/DT such/JJ data/NNS ]
./. 

''/'' 
======================================

[ Ciba-Geigy/NNP 's/POS campaigns/NNS ]
often/RB include/VBP 
[ lobbying/NN support/NN ]
from/IN 
[ the/DT Epilepsy/NNP Institute/NNP ]
,/, 
[ a/DT patient-advocacy/NN organization/NN ]
./. 

[ The/DT Institute/NNP ]
has/VBZ issued/VBN 
[ statements/NNS ]
claiming/VBG that/IN 
[ it/PRP ]
has/VBZ ``/`` 
[ anecdotal/JJ reports/NNS ]
''/'' of/IN 
[ patients/NNS ]

[ who/WP ]
had/VBD 
[ seizures/NNS ]
after/IN switching/VBG to/TO 
[ a/DT generic/JJ ]
,/, but/CC 
[ investigations/NNS ]
by/IN 
[ the/DT FDA/NNP ]
and/CC 
[ others/NNS ]
have/VBP failed/VBN to/TO verify/VB 
[ the/DT problems/NNS ]
./. 

Meanwhile/RB ,/, 
[ the/DT Institute/NNP ]
acknowledges/VBZ 
[ it/PRP ]
receives/VBZ ``/`` 
[ educational/JJ ]
''/'' funding/NN from/IN 
[ Ciba-Geigy/NNP ]
and/CC 
[ other/JJ brand-name/JJ drug/NN makers/NNS ]
./. 

[ A/DT San/NNP Francisco/NNP chapter/NN ]

[ which/WDT ]
lobbied/VBD for/IN 
[ the/DT California/NNP law/NN ]
said/VBD 
[ Ciba-Geigy/NNP ]
gave/VBD 
[ it/PRP ]

[ a/DT $/$ 20,000/CD educational/JJ grant/NN ]

[ this/DT year/NN ]
./. 

======================================

In/IN 
[ Summit/NNP ]
,/, 
[ N.J./NNP ]
,/, 
[ a/DT spokeswoman/NN ]
for/IN 
[ Ciba-Geigy/NNP ]
says/VBZ ,/, ``/`` 
[ We/PRP ]
have/VBP 
[ anecdotal/JJ data/NNS ]
to/TO back/VB 
[ our/PRP$ claim/NN ]
that/IN switching/VBG|NN does/VBZ 
[ cause/NN seizures/NNS ]
among/IN 
[ a/DT small/JJ population/NN ]
of/IN 
[ sensitive/JJ people/NNS ]
./. 

''/'' 
======================================

[ Schering-Plough/NNP Corp./NNP ]
,/, 
[ Madison/NNP ]
,/, 
[ N.J./NNP ]
,/, also/RB has/VBZ waged/VBN 
[ aggressive/JJ ]
``/`` 
[ anti-switching/JJ ]
''/'' 
[ campaigns/NNS ]

[ that/WDT ]
have/VBP upset/VBN 
[ the/DT FDA/NNP ]
./. 

Schering/NNP sells/VBZ 
[ a/DT special/JJ version/NN ]
of/IN 
[ the/DT asthma/NN drug/NN theopylline/NN ]
,/, under/IN 
[ the/DT brand/NN name/NN Theo-Dur/NNP ]
,/, and/CC has/VBZ claimed/VBN in/IN marketing/NN 
[ materials/NNS ]
that/IN substituting/VBG 
[ any/DT product/NN ]
for/IN 
[ Theo-Dur/NNP ]
is/VBZ dangerous/JJ ./. 

======================================

In/IN 
[ a/DT letter/NN ]
to/TO Schering/NNP 
[ 's/POS chairman/NN ]
,/, 
[ Robert/NNP Luciano/NNP ]
,/, 
[ the/DT FDA/NNP ]
said/VBD ``/`` 
[ your/PRP$ firm/NN ]
has/VBZ employed/VBN 
[ falsehoods/NNS ]
,/, 
[ misrepresentations/NNS ]
,/, and/CC innuendo/NN on/IN 
[ a/DT continuing/JJ basis/NN ]
and/CC in/IN 
[ the/DT absence/NN ]
of/IN 
[ any/DT valid/JJ scientific/JJ data/NNS ]
,/, in/IN 
[ an/DT effort/NN ]
to/TO convince/VB 
[ the/DT medical/JJ ]
and/CC 
[ pharmaceutical/JJ communities/NNS ]
that/IN 
[ Theo-Dur/NNP ]
is/VBZ superior/JJ to/TO 
[ all/DT alternative.../: theophylline/NN products/NNS ]
./. 

''/'' 
======================================

In/IN 
[ a/DT response/NN ]
to/TO 
[ the/DT FDA/NNP ]
in/IN 
[ March/NNP ]
,/, 
[ Schering/NNP ]
said/VBD 
[ it/PRP ]
would/MD revise/VB 
[ some/DT ]
of/IN 
[ its/PRP$ practices/NNS ]
to/TO conform/VB with/IN 
[ FDA/NNP guidelines/NNS ]
./. 

======================================

[ This/DT sort/NN ]
of/IN 
[ conflict/NN ]
,/, and/CC 
[ other/JJ battles/NNS ]
in/IN 
[ the/DT industry/NN ]
,/, are/VBP expected/VBN to/TO escalate/VB in/IN coming/JJ 
[ years/NNS ]
as/IN 
[ more/JJR generics/NNS ]
come/VBD on/IN 
[ the/DT market/NN ]
and/CC 
[ more/JJR patents/NNS ]
on/IN 
[ brand-name/JJ drugs/NNS ]
expire/VBP ./. 

Already/RB ,/, 
[ the/DT number/NN ]
of/IN 
[ prescriptions/NNS ]
written/VBN 
[ each/DT year/NN ]
has/VBZ flattened/VBN out/RP ,/, so/RB 
[ a/DT growing/VBG number/NN ]
of/IN 
[ drug/NN companies/NNS ]
are/VBP chasing/VBG 
[ a/DT static/JJ amount/NN ]
of/IN 
[ business/NN ]
./. 

======================================

Moreover/RB ,/, 
[ state/NN ]
and/CC 
[ private/JJ health/NN care/NN officials/NNS ]
have/VBP tasted/VBN 
[ the/DT chief/JJ benefit/NN ]
of/IN using/VBG 
[ generics/NNS ]
--/: 
[ their/PRP$ relative/JJ low/JJ cost/NN ]
--/: and/CC ,/, if/IN 
[ anything/NN ]
,/, will/MD only/RB be/VB looking/VBG for/IN 
[ new/JJ ways/NNS ]
to/TO use/VB 
[ the/DT non-brand/JJ drugs/NNS ]
./. 

[ Thomas/NNP Culkin/NNP ]
,/, 
[ an/DT official/NN ]
with/IN 
[ the/DT health/NN department/NN ]
in/IN 
[ New/NNP Jersey/NNP ]
,/, for/IN 
[ example/NN ]
,/, says/VBZ 
[ his/PRP$ Medicaid/NNP program/NN ]
saved/VBN 
[ $/$ 11/CD million/CD ]
in/IN 
[ 1988/CD ]
by/IN substituting/VBG 
[ generics/NNS ]
for/IN 
[ brand-name/JJ drugs/NNS ]
./. 

``/`` 
[ Smart/JJ economics/NN dictates/NNS we/PRP ]
use/VBP 
[ more/JJR generics/NNS ]
,/, ''/'' 
[ he/PRP ]
says/VBZ ./. 
